Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemifloxacin Versus Ciprofloxacin Versus Rifampicin in Treatment of Rhinoscleroma

NCT03326050 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03326050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03326050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemifloxacin Versus Ciprofloxacin Versus Rifampicin in Treatment of Rhinoscleroma
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2018
Completion date
October 31, 2018
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoscleroma